Guideline Recommendations on N‑Acetylcysteine (NAC) Use in Fertility Treatment

Male Infertility

• AUA/ASRM (2021) recommendation – Clinicians should counsel patients that supplements, including antioxidants such as NAC, have questionable clinical utility for treating male infertility because data are inadequate to support any specific agent. Strength: weak/conditional recommendation. 1
• WHO (2017) guideline – There is insufficient evidence to endorse supplemental antioxidant therapy (e.g., NAC) for men with abnormal semen parameters or diagnosed male infertility. Strength: strong recommendation against use. 2
• Therapeutic alternatives – In men with low testosterone who wish to preserve fertility, aromatase inhibitors, human chorionic gonadotropin (hCG), or selective estrogen receptor modulators (SERMs) may be employed; NAC is not recommended. Strength: expert consensus. 1
• Idiopathic infertility – Follicle‑stimulating hormone (FSH) analogues can be considered; SERMs provide limited benefit compared with assisted reproductive technology (ART). Strength: expert consensus. 1
• Testosterone monotherapy warning – Testosterone alone should never be prescribed to men desiring fertility because it suppresses spermatogenesis. Strength: strong recommendation. 1
• Diagnostic work‑up – Perform a comprehensive semen analysis and hormonal evaluation before initiating any treatment. Strength: guideline standard. 1
• Modifiable risk factor management – Advise weight loss in overweight/obese men, complete smoking cessation, and avoidance of testosterone therapy to improve sperm parameters. Strength: guideline standard. 1
• Assisted reproductive technology – When indicated, refer patients for IVF/ICSI as a definitive treatment option. Strength: guideline standard. 1
• Supplement use – Do not recommend NAC or other antioxidant supplements for male infertility. Strength: strong recommendation against use. 1

Female Infertility (PCOS and Unexplained)

• Guideline stance on NAC – Routine addition of NAC to treatment regimens for women with PCOS or unexplained infertility is not advised because evidence is insufficient and study results are highly heterogeneous. Strength: strong recommendation against routine use. 1
• First‑line pharmacotherapy – Clomiphene citrate or letrozole alone remain the primary medical options; metformin is preferred over NAC for clomiphene‑resistant cases. Strength: guideline standard (citation 1 for ART referral, but first‑line recommendation inferred from guideline context). 1
• ART referral – If first‑line agents fail, proceed to assisted reproductive technology. Strength: guideline standard. 1

Overall Evidence Summary

• Lack of high‑quality support for NAC – Current medical guidelines (AUA/ASRM 2021; WHO 2017) do not recommend N‑acetylcysteine for improving fertility outcomes in either sex, citing questionable clinical utility and insufficient high‑quality evidence. Strength: strong recommendation against use. 1, 2
• Safety vs. efficacy – Although NAC appears well‑tolerated, the absence of consistent benefit, high heterogeneity across studies, and no data on live‑birth rates mean clinicians should prioritize evidence‑based interventions rather than NAC supplementation. Strength: expert consensus. 1, 2

Nutrition and Lifestyle Recommendations for Infertility

Essential Preconception Nutritional Interventions

• The American Academy of Family Physicians recommends taking 400-800 mcg of folic acid daily starting before conception and continuing through 12 weeks of pregnancy to reduce neural tube defects 3
• The Centers for Disease Control and Prevention recommends consuming a balanced diet of folate-rich foods in addition to supplementation and avoiding fish with high mercury levels 3, 4
• Completely abstain from alcohol, tobacco, and recreational drugs, as recommended by the American Academy of Family Physicians and the Centers for Disease Control and Prevention 3, 4

Dietary Pattern Recommendations

• The European Association of Urology recommends weight loss in overweight or obese men to enhance sperm parameters 5, 6
• The Centers for Disease Control and Prevention recommends avoiding trans fats, processed meats, and high-glycemic foods 4

Key Nutrients and Antioxidants

• The American Urological Association and American Society for Reproductive Medicine state that there are no clear, reliable data supporting supplements for improving fertility outcomes, though they are likely not harmful 7, 8, 5
• The European Association of Urology recommends that men seeking fertility should never use testosterone therapy as it suppresses FSH and LH, causing azoospermia that can take months to years to recover 5, 6

Lifestyle Modifications Beyond Diet

• The American College of Obstetricians and Gynecologists recommends complete smoking cessation to improve sperm quality and overall health 9, 10, 5, 6
• The European Association of Urology recommends regular physical exercise to improve sperm parameters and overall health 5, 6
• The Centers for Disease Control and Prevention recommends counseling on maximizing fertility, including timing intercourse to the 6-day fertile window ending on ovulation day and having vaginal intercourse every 1-2 days after menstrual period ends 4

Antioxidant Supplementation and Lifestyle Management in Male Infertility

Guideline Stance on Antioxidant Supplements (including NAC)

• The American Urological Association / American Society for Reproductive Medicine (AUA/ASRM) 2021 guideline states that there is no clear, reliable evidence that antioxidant supplements improve male fertility outcomes; such supplements are of questionable clinical value and are strongly recommended against. 11
• The European Association of Urology (EAU) 2025 guideline notes that the evidence for antioxidant therapy in male infertility is low‑quality and conflicting; after removing studies with high risk of bias, no significant increase in live‑birth rates is observed, leading to a weak recommendation against routine antioxidant use. 12
• The Urology guideline 2024 reports that no comparative trials demonstrate NAC (or any antioxidant) superiority over assisted reproductive technologies (ART), which remain the gold standard for male‑factor infertility. No recommendation for NAC. 13

Lifestyle Interventions with Proven Benefit

• Weight loss in overweight/obese men improves semen volume, concentration, motility, and morphology; the EAU 2025 guideline gives a strong recommendation for weight reduction as first‑line therapy. 12
• Complete smoking cessation is associated with measurable improvements in sperm quality and overall health; the EAU 2025 guideline issues a strong recommendation for quitting tobacco. 12
• Regular physical exercise enhances sperm parameters and cardiovascular health; the EUA 2025 guideline provides a strong recommendation for incorporating regular activity. 12

Required Diagnostic Evaluation Before Treatment

• Comprehensive seminal analysis (minimum two separate samples collected 2–3 months apart) is mandatory prior to any therapeutic decision. EAU 2025. 12
• Hormonal profiling (FSH, LH, total testosterone, SHBG) is a required component of the initial work‑up. EAU 2025. 12
• Physical examination assessing testicular volume and the presence of varicocele is essential in baseline evaluation. EAU 2025. 12
• Genetic testing (karyotype and Y‑chromosome microdeletions) is indicated when sperm concentration is < 5 million/mL. EAU 2025. 12

Surgical and Assisted Reproductive Technology (ART) Pathways

• In men with a clinically palpable varicocele and abnormal semen parameters, varicocelectomy improves sperm quality and fertility rates; surgery is preferred over antioxidant supplementation. Strong recommendation (EAU 2025). 12
• Exogenous testosterone therapy suppresses the hypothalamic‑pituitary‑gonadal axis, leading to azoospermia; it is strongly contraindicated in men desiring fertility. (EAU 2025). 12
• When total motile sperm count is < 10 million on repeated analyses, direct referral to ART (IVF/ICSI) is advised. Strong recommendation (AUA/ASRM 2021; Urology guideline 2024). [11][13]
• In cases of elevated FSH (> 7.6 IU/L) with testicular atrophy, micro‑TESE yields sperm retrieval rates of ≈ 40–50 %. EAU 2025. 12

Risks of Unproven Supplement Use

• Attempting antioxidant supplementation (e.g., NAC) can delay ART by 3–6 months, potentially reducing success because of advancing female age. Moderate recommendation to avoid such delay (EAU 2025; AUA/ASRM 2021; Urology guideline 2024). [12][11]13
• No clinical trials have demonstrated that NAC improves pregnancy or live‑birth outcomes; existing studies only report changes in semen parameters, providing no evidence of clinically meaningful benefit. (EAU 2025). 12
• High heterogeneity and variable methodological quality across NAC studies limit interpretability; when high‑risk‑bias studies are excluded, any apparent benefits disappear. EAU 2025. 12